ST
INO icon

Spot Trading’s Inovio Pharmaceuticals INO Stock Holding History

Spot Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-250
Closed -$21K – 3114
2016
Q4 		$21K Hold
250
– – ﹤0.01% 2554
2016
Q3 		$28K Sell
250
-83
-25% -$9.17K ﹤0.01% 2756
2016
Q2 		$37K Buy
333
+100
+43% +$12.1K ﹤0.01% 2845
2016
Q1 		$24K Buy
+233
New +$18K ﹤0.01% 2990
2014
Q3 		– Sell
-867
Closed -$112K – 4490
2014
Q2 		$112K Buy
+867
New +$102K ﹤0.01% 3647

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Spot Trading's INO Position: Q1 2017 in Review

Spot Trading sold out of Inovio Pharmaceuticals (INO) in Q1 2017, closing a stake of 11 shares — an estimated $1K sold.

Spot Trading first reported a position in INO in Q2 2014 and held it in 4 quarters. The position peaked at $65K in Q2 2016. 106 funds tracked by Wall St. Rank hold INO as of Q1 2017.

  • Spot Trading reported no remaining Inovio Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 11 Inovio Pharmaceuticals shares in Q1 2017, an estimated $1K.
  • Spot Trading first reported a position in Inovio Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Spot Trading's Inovio Pharmaceuticals position peaked at $65K in Q2 2016.
  • 106 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.